As of 2025-06-23, the Relative Valuation of SpringWorks Therapeutics Inc (SWTX) is (69.79) USD. This relative valuation is based on P/E multiples. With the latest stock price at 46.96 USD, the upside of SpringWorks Therapeutics Inc based on Relative Valuation is -248.6%.
The range of the Relative Valuation is (55.63) - (78.89) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.0x - 23.4x | 19.2x |
| Forward P/E multiples | 16.5x - 27.9x | 22.2x |
| Fair Price | (55.63) - (78.89) | (69.79) |
| Upside | -218.5% - -268.0% | -248.6% |
| Date | P/E |
| 2025-06-16 | -13.90 |
| 2025-06-13 | -13.88 |
| 2025-06-12 | -13.87 |
| 2025-06-11 | -13.87 |
| 2025-06-10 | -13.86 |
| 2025-06-09 | -13.87 |
| 2025-06-06 | -13.88 |
| 2025-06-05 | -13.88 |
| 2025-06-04 | -13.85 |
| 2025-06-03 | -13.87 |
| 2025-06-02 | -13.84 |
| 2025-05-30 | -13.85 |
| 2025-05-29 | -13.85 |
| 2025-05-28 | -13.85 |
| 2025-05-27 | -13.78 |
| 2025-05-23 | -13.79 |
| 2025-05-22 | -13.72 |
| 2025-05-21 | -13.71 |
| 2025-05-20 | -13.74 |
| 2025-05-19 | -13.72 |
| 2025-05-16 | -13.68 |
| 2025-05-15 | -13.67 |
| 2025-05-14 | -13.71 |
| 2025-05-13 | -13.71 |
| 2025-05-12 | -13.68 |
| 2025-05-09 | -13.72 |
| 2025-05-08 | -13.70 |
| 2025-05-07 | -13.70 |
| 2025-05-06 | -13.69 |
| 2025-05-05 | -13.71 |
| 2025-05-02 | -13.71 |
| 2025-05-01 | -13.71 |
| 2025-04-30 | -13.73 |
| 2025-04-29 | -13.72 |
| 2025-04-28 | -13.70 |
| 2025-04-25 | -13.26 |
| 2025-04-24 | -13.33 |
| 2025-04-23 | -12.22 |
| 2025-04-22 | -12.01 |
| 2025-04-21 | -10.99 |
| 2025-04-17 | -11.25 |
| 2025-04-16 | -11.19 |
| 2025-04-15 | -11.15 |
| 2025-04-14 | -11.11 |
| 2025-04-11 | -10.82 |
| 2025-04-10 | -10.21 |
| 2025-04-09 | -11.01 |
| 2025-04-08 | -10.59 |
| 2025-04-07 | -10.97 |
| 2025-04-04 | -11.59 |